# A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors

Source: https://onco.cc/trials/nct05240898/  
OnCo record `nct05240898` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1 trial of KSQ-4279 run by Hoffmann-La Roche, completed.

## Summary

A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors is a phase 1 interventional study registered as NCT05240898 by Hoffmann-La Roche, with 116 participants enrolled, started 2021-08-26, primary completion reached 2025-11-26. Conditions recorded: Advanced Solid Tumors. Interventions recorded: RO7623066, Olaparib, Carboplatin.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-11-04
- Tags: pipeline; ctgov-ingest
- Registry id: NCT05240898
- Phase: 1
- Setting: A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors
- Sponsor: Hoffmann-La Roche
- Enrolled: 116

## Sources

- ClinicalTrials.gov NCT05240898: https://clinicaltrials.gov/study/NCT05240898

## Connected records

- drugs: [KSQ-4279](https://onco.cc/drugs/ksq-4279/)
- companies: [KSQ Therapeutics](https://onco.cc/companies/ksq-therapeutics/)

---
JSON: https://onco.cc/api/v1/entities/nct05240898.json